← Open Payments lookup

MICHAEL RAIDA: Open Payments

NPI 1518910389 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,477 in 59 payments from 15 companies in 2025. Trend: 2023 $1,736 · 2024 $1,995 · 2025 $1,477

Food & beverage: $1,477
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$279
ABBVIE INC.12$244
Otsuka America Pharmaceutical, Inc.6$193
Axsome Therapeutics, Inc.4$116
Almatica Pharma LLC4$107
Takeda Pharmaceuticals U.S.A., Inc.4$88
E.R. Squibb & Sons, L.L.C.4$82
Vanda Pharmaceuticals Inc.3$75
Janssen Pharmaceuticals, Inc2$68
Corium, LLC2$64

Products named: CAPLYTA, VRAYLAR, REXULTI, Auvelity, LOREEV XR, TRINTELLIX, COBENFY, FANAPT.

Industry payments across IL — which companies pay providers there.